Design and Characterization of a New Formulation for the Delivery of COVID-19-mRNA Vaccine to the Nasal Mucosa.
- Resource Type
- Article
- Source
- Vaccines; Apr2024, Vol. 12 Issue 4, p409, 25p
- Subject
NASAL mucosa SARS-CoV-2 EPITHELIAL cells DENDRITIC cells ANTIBODY formation - Language
- ISSN
- 2076393X